Furthermore, we validated the RECK mRNA expression by real-time quantitative reverse transcription-PCR (qPCR), and our results showed that the RECK mRNA level was significantly lower in malignant gliomas compared to lower grade gliomas and non-tumor brain tissues (Figure 5B,C). This evidence concerns the gene RECK and central nervous system cancer.